Stock LTRN LANTERN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-03 EDT 		5-day change 1st Jan Change
6.15 USD +12.02% Intraday chart for Lantern Pharma Inc. +11.82% +43.69%
04-24 Transcript : Lantern Pharma Inc. - Special Call
04-22 Lantern Gets Regulatory Approval in Japan, Taiwan for Non-Small Cell Lung Cancer Trial Expansion MT

Evolution of the average Target Price on Lantern Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

b81bb5a96794286bbd992cd8d6e63.nCTSNMynIUNOUu8EtV29Uo92iCaHRsHGCjBBDVN7Z7c.ynG_cpvoeCwFGdZS4gLVGM5B7EjBAJv-c2EgSBwcCNWoT5l3tZJQLzdirg~1e78bbe3f9ab8ba0df6f917641abab9c

Analyst Recommendations on Lantern Pharma Inc.

HC Wainwright Starts Lantern Pharma at Neutral MT
EF Hutton Starts Lantern Pharma at Buy With $11 Price Target MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $34 From $32, Keeps Buy Rating MT
LANTERN PHARMA : HC Wainwright Starts Lantern Pharma at Buy with $32 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.15 USD
Average target price
22 USD
Spread / Average Target
+257.72%
High Price Target
26 USD
Spread / Highest target
+322.76%
Low Price Target
18 USD
Spread / Lowest Target
+192.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lantern Pharma Inc.

HC Wainwright
EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LTRN Stock
  4. Consensus Lantern Pharma Inc.